Chloramphenicol in the 1980s

Drugs

Volumn 28, Issue 4, 1984, Pages 281-291

  Shalit, Itamar ^a   Marks, Melvin I ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CHLORAMPHENICOL HEMISUCCINATE; CHLORAMPHENICOL PALMITATE; COTRIMOXAZOLE; PENICILLIN G;

ADVERSE DRUG REACTION; APLASTIC ANEMIA; BACTEROIDES; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; DRUG DOSE; DRUG INTERACTION; DRUG THERAPY; DRUG TOXICITY; GRAY BABY SYNDROME; HAEMOPHILUS INFLUENZAE; HUMAN; INTOXICATION; PHARMACOKINETICS; REVIEW; STREPTOCOCCUS PNEUMONIAE; THERAPY;

ADULT; ANIMAL; BACTERIA; BACTERIAL INFECTIONS; CHLORAMPHENICOL; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; HUMAN; INFANT, NEWBORN; KINETICS;

EID: 0021228217     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198428040-00001     Document Type: Article

References (112)

1. Comparative clinical trial of amoxycillin and chloramphenicol in the treatment of typhoid in adults
2. Marrow aplasia following topical application of chloramphenicol eye ointment
3. Chloramphenicol-responsive chronic neutropenia
4. Penicillin insensitive pneumococci
5. Streptococcus pneumoniae resistant to penicillin and chloramphenicol
6. Simultaneous measurements of chloramphenicol and chloramphenicol succinate in body fluids utilizing HPLC
7. Ampicillin-chloramphenicol interaction against enteric Gram-negative organisms
8. Typhoid fever in the United States associated with the 1972–1973 epidemic in Mexico
9. Chloramphenicol bioassay
10. A 12-year review of the antibiotic management of Haemophilus influenzae meningitis: Comparison of ampicillin and conventional therapy including chloramphenicol
11. Factors affecting the intraocular penetration of antibiotics
12. Chloramphenicol resistance mutation in Escherichia coli which maps in the major ribosomal protein gene cluster
13. Chloramphenicol-associated blood dyscrasis
14. Chloramphenicol and phenobarbitone —a drug interaction
15. Low-dose chloramphenicol stimulates granulocyte/monocyte colony-forming units
16. Antibiotic management of anaerobic infections
17. Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique
18. Interaction between chloramphenicol and paracetamol
19. Fatal circulatory collapse in premature infants receiving chloramphenicol
20. Chloramphenicol resistant typhoid fever in Vietnam associated with R factor
21. Haemophilus influenzae type b resistant to ampicillin and chloramphenicol
22. Pneumococcal meningitis caused by chloramphenicol and tetracycline resistant type 23 pneumococcus —Australia
23. Ampicillin and chloramphenicol resistance in systemic Haemophilus influenzae disease
24. ln-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b
25. An enzymatic assay for chloramphenicol with partially purified chloramphenicol acetyl transferase
26. Effect of chloramphenicol on in vitro function of lymphocytes
27. Fatal aplastic anemia following apparent ‘dose-related’ chloramphenicol toxicity
28. Hydrolysis and absorption of chloramphenicol palmitate
29. Central nervous system chloramphenicol concentration in premature infants
30. Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and Rocky Mountain spotted fever
31. Chloromycetin, a new antibiotic from a soil actinomycete
32. Effect of ampicillin and chloramphenicol against Haemophilus inftuenzae.
33. Effect of ampicillin and chloramphenicol against Streptococcus pneumoniae and Neisseria meningitidis.
34. Anaerobic bacterial endocarditis
35. Effects of chloramphenicol and its isomers and analogues on the mitochondrial respiratory chain
36. Inhibition of mitochondrial and bacterial protein synthesis by chloramphenicol
37. Meningitis due to beta lactamase producing type b Haemophilus influenzae resistant to chloramphenicol
38. Biochemical studies on chloramphenicol (Chloromycetin). I. Colorimetric methods for determination of chloramphenicol and related nitrocompounds
39. Physical factors affecting the rate of absorption of chloramphenicol esters
40. Ampicillin-resistant Haemophilus influenzae.
41. Statewide survey of the antimicrobial susceptibilities of Haemophilus influenzae producing invasive disease in Tennessee
42. Treatment of experimental brain abscess with penicillin and chloramphenicol
43. Drug treatment of typhoid fever
44. Studies on chloramphenicol. 1. Assessment of haemopoietic toxicity
45. Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: A prevalence study in metropolitan Denver
46. Cefuroxime versus ampicillin and chloramphenicol for the treatment of bacterial meningitis
47. Evaluation of therapeutic efficacy of trimethoprimsulphamethoxazole and chloramphenicol in enteric fever
48. Studies on the mechanism of chloramphenicol impairment of human leukocyte function (34778)
49. Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children
50. Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol
51. Chloramphenicol toxicity in a neonate treated with exchange transfusion
52. Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b
53. Bactericidal activity of the combination of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis.
54. High-performance liquid Chromatographic graphic assay of chloramphenicol in serum
55. Pharmacologie interactions among chloramphenicol, phenytoin and phenobarbital
56. Chloramphenicol, erythromycin, vancomycin, tetracyclines
57. Central nervous system toxicity associated with metronidazole therapy
58. Chloramphenicol: Properties and clinical use
59. On the gray syndrome’ and chloramphenicol toxicity
60. Meningitis in a Canadian infant due to pneumococcus resistant to penicillin and chloramphenicol
61. Chloramphenicol and the neonate —1979 view
62. Randomised, comparative trial of mecillinam, mecillinam/ampicillin and chloramphenicol in the treatment of enteric fever
63. Chloramphenicol-induced erythroid suppression and bone marrow ferrochelatase in dogs
64. Chloramphenicol. Recent developments and clinical indications
65. Chloramphenicol toxicity —oral vs. intravenous administration
66. Treatment of an infant with severe chloramphenicol intoxication using charcoal column hemoperfusion
67. New concepts in the management of infants and children with meningitis
68. Susceptibility of microorganisms to chloramphenicol (Chloromycetin)
69. The pharmacokinetics of chloramphenicol in the neonate and young infant
70. Chloramphenicol toxicity in neonates: Its incidence and prevention
71. The efficacy of chloramphenicol in the treatment of neonatal and infantile meningitis; a study of 70 cases
72. Concordance for drug-induced aplastic anemia in identical twins
73. Chloramphenicol serum concentration falls during chloramphenicol succinate dosing
74. Salmonella typhi resistant to chloramphenicol, ampicillin and other antimicrobial agents: Strains isolated during an extensive typhoid fever epidemic in Mexico
75. Hematologic consequences of chloramphenicol therapy
76. Absorption of chloramphenicol palmitate in patients with cystic fibrosis (CF)
77. Inhibitors of ribosome function
78. Clinical pharmacology of two chloramphenicol preparations in children: Sodium succinate (iv) and palmitate (oral) esters
79. Identification of chloramphenicol-binding protein in Escherichia coli ribosomes by affinity labeling
80. Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient
81. Multiply resistant pneumococcus causing meningitis: Its epidemiology within a day-care center
82. Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens
83. Antibiotic therapy for severe infections in infants and children
84. A fatal case of aplastic anemia following chloramphenicol (Chloromycetin) therapy
85. Characterization of chloramphenicol resistant Haemophilus influenzae.
86. The use of Chloromycetin palmitate in infants and children: A preliminary report
87. Chloramphenicol pharmacokinetics in infants and young children
88. Chloramphenicol succinate kinetics in infants and young children
89. Effect of chloramphenicol on erythropoiesis
90. A current review of brain abscess
91. Uber die Spaltung von Chloramphenicolsuccinate durch tierische un menschliche Gewebe
92. Comparative enzymology of chloramphenicol resistance
93. Haemophilus influenzae type b resistant to ampicillin and chloramphenicol in an orphanage in Thailand
94. Pharmacology of chloramphenicol
95. Mechanism of high-level resistance to chloramphenicol in different E. coli variants
96. Comparison of ceftriaxone with standard therapy for bacterial meningitis
97. Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits
98. Apparent failure of chloramphenicol in the treatment of anarobic infections
99. Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis
100. Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol
101. Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis
102. Statewide study of chloramphenicol therapy and fatal aplastic anemia
103. Tetracyclines, chloramphenicol, erytnromycin and clindamycin
104. Studies on the concentration of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants and small children
105. Delayed bactericidal activity of β-lactam antibiotics against Listeria monocytogenes: Antagonism of chloramphenicol and rifampin
106. Ventricular fluid levels of chloramphenicol in infants
107. Drug-induced bone marrow injury
108. Chloramphenicol-induced bone marrow suppression
109. 2 in aplastic anemia